BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTAMP:20240328T232053Z
UID:cf41744a-c8e0-4188-8189-6f69b21fec5a
DTSTART:20230307T093000
DTEND:20230309T153000
CLASS:PRIVATE
DESCRIPTION:
\nIt has lon
g been understood that the ability to deliver therapeutic cargos to cytoso
lic sites of action in target tissue could unlock access to previously und
ruggable targets\, whilst enabling the development of safer and efficaciou
s drugs.
\n
\nNow\, advances in nanomedicine technology\, the LN
P-enabled mRNA vaccine and modern medicine'\;s shift towards a more per
sonalized model are fuelling excitement amongst drug developers as they po
sition their pipelines towards utilizing novel delivery systems which effe
ctively engage previously elusive intracellular targets.
\n
\nWi
th mounting investments\, industry collaborations and interest in leveragi
ng next-generation nano vehicles\, from LNP'\;s\, liposomes\, EV'\;s
\, polymeric nanoparticles (and beyond!)\, new avenues have been opened fo
r optimizing the therapeutic index of novel pipelines\, from antisense oli
gonucleotides\, siRNA\, mRNA and DNA delivery to peptide protein drugs.
\n
\nIt'\;s timely for the Targeted Intracellular Delivery Summ
it to arrive as your only industry dedicated forum\, focussed on accelerat
ing the mechanistic understanding and potential of much-needed intracellul
arly delivery technologies through exploiting an advanced understanding of
membrane biology and biological barriers.
\n
\nUniting the lead
ing minds of large pharma\, biotech and academia\, unite with Formulation\
, Chemistry\, Delivery and Biology as industry showcases the pioneering di
scoveries\, critical findings and novel approaches fast-tracking  \;pr
omising candidates towards the clinic.
\n
\nGroup discounts and
early booking rates are available. Please visit the website for full prici
ng information.
\n
\nURLs:
\nTickets: https://go.evvnt.com/1443409
-2?pid=1052
\nBrochure: https://go.evvnt.com/1443409-3?pid=1052
\n
\nPrices:
\nDrug Developer - Conference + 1 Workshop: USD 36
48.00\,
\nDrug Developer - Conference Only: USD 2999.00\,
\nSolu
tion and Service Provider - Conference + 1 Workshop: USD 4348.00\,
\n
Solution and Service Provider - Conference Only: USD 3599.00
\n
\nSpeakers: Allen Horhota\, Senior Director\, Head of Del
ivery\, Orna Therapeutics\, Avidor Shulman\, Chief Technology Officer\, Bi
ond Biologics\, Ben Spangler\, Senior Scientist\, BioMarin Pharmaceutical\
, Christopher Locher\, Chief Executive Officer\, Versatope\, David Guay\,
Vice President\, Innovation and Technology\, Feldan Therapeutics\, De-Min
Zhu\, President and Chief Executive Officer\, Cureport\, Ernst Wagner\, Pr
ofessor\, Ludwig- Maximilians- Universitä\;t Mü\;nchen\, Fionnuala
Lane\, Program Director\, Targeted Drug Delivery Series\, Gibeom Kim\, La
boratory Director\, ShiftBio\, Guy Hermans\, Chief Executive Officer\, Sap
reme Technologies\, Heinrich Haas\, Vice President\, RNA Formulation and D
rug Delivery\, BioNTech\, James Ferguson Chief Medical Officer\, Matinas B
ioPharma\, Kalina Paunovska\, Co-Founder\, Nava Therapeutics\, Manmohan Si
ngh\, Chief Technology Officer\, Beam Therapeutics\, Michael Munson\, Seni
or Research Scientist\, AstraZeneca\, Niren Murthy\, Professor\, Departmen
t of Bioengineering\, University of California\, Berkeley\, Qi-Ying Hu\, V
ice President\, Head of Formulation and Delivery\, Omega Therapeutics\, Ru
i Zhang\, Associate Director\, LNP Formulation\, Tessera Therapeutics\, Se
an Bedingfield\, Research Engineer\, Lilly Genetic Medicine\, Eli Lilly an
d Company\, Shalom Goldberg\, Senior Principal Scientist\, Johnson and Joh
nson
SUMMARY:Targeted Intracellular Delivery Summit
BEGIN:VALARM
ACTION:DISPLAY
TRIGGER:-PT1H
SUMMARY:Targeted Intracellular Delivery Summit
END:VALARM
END:VEVENT
END:VCALENDAR